The natural history of vincristine-induced laryngeal paralysis in children

Archives of Otolaryngology - Head and Neck Surgery

Volumn 135, Issue 1, 2009, Pages 101-105

  Kuruvilla, George ^a,b,c,e   Perry, Shirley ^c,d,e   Wilson, Beverly ^c,d,e   El Hakim, Hamdy ^a,b,e  

^a Pediatric Otolaryngology Service   (Canada)

^b Division of Otolaryngology   (Canada)

^c Department of Pediatrics ^*  (Canada)

^d Division of Hematology and Oncology   (Canada)

^e STOLLERY CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; AGE DISTRIBUTION; ARTICLE; CASE STUDY; CHILD; CLINICAL ARTICLE; COMORBIDITY; DATA BASE; DEMOGRAPHY; DISEASE COURSE; DISEASE DURATION; DOWN SYNDROME; DRUG INDUCED DISEASE; EMBRYONAL RHABDOMYOSARCOMA; EPENDYMOMA; FEMALE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; INFANT; LARYNGOSCOPY; LARYNX DISORDER; LARYNX PARALYSIS; MALE; MEDICAL INFORMATION; MEDICAL RECORD REVIEW; MEDLINE; OUTCOME ASSESSMENT; PEDIATRIC HOSPITAL; POSITIVE END EXPIRATORY PRESSURE; PRESCHOOL CHILD; PREVALENCE; PUBLICATION; RETROSPECTIVE STUDY; SCHOOL CHILD; SEX RATIO; T CELL LYMPHOMA; TERTIARY HEALTH CARE; TREATMENT DURATION; VINCRISTINE INDUCED LARYNGEAL PARALYSIS; VOCAL CORD; VOCAL CORD PARALYSIS;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; NEOPLASMS; RETROSPECTIVE STUDIES; VINCRISTINE; VOCAL CORD PARALYSIS;

EID: 58849143800     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archoto.2008.514     Document Type: Article

References (18)

1. Anghelescu DL, De Armencli AJ, Thompson JW, Sillos EM, Pui CH, Sandiund JT. Vincristine-induced vocal cord paralysis in an infant. Paediatr Anaesth. 2002; 12(2):168-170.
2. Bradley WG, Lassman LP, Pearce GW, Walton JN. The neuromyopathy of vin cristine in man: clinical, electrophysiological, and pathological studies. J Neurol Sci. 1970;10(2):107-131.
3. Sahenk Z, Brady ST, Mendell JR. Studies on the pathogenesis of vincristineinduced neuropathy. Muscle Nerve. 1987;10(1):80-84.
4. Tuxen MK, Hansen SW. Neurotoxicity secondary to antineoplastic drugs. Cancer Treat Rev. 1994;20(2):191-214.
5. Bohannon RA, Miller DG, Diamond HD. Vincristine in the treatment of lymphomas and leukemia. Cancer Res. 1963;23:613-621.
6. Tobias JD, Bozeman PM. Vincristine-induced recurrent laryngeal nerve paralysis in children. Intensive Care Med. 1991;17(5):304-305.
7. Annino DJ Jr, MacArthur CJ, Friedman EM. Vincristine-induced recurrent laryngeal nerve paralysis. Laryngoscope. 1992;102(11):1260-1262.
8. Chauvenet AR, Shashi V, Selsky C, et al. Vincristine-induced neuropathy as the initial presentation of Charcot-Marie-Tooth disease in acute lymphoblastic leukemia: a pediatric Oncology Group study. J Pediatr Hematol Oncol. 2003;25 (4):316-320.
9. Ahmed A, Williams D, Nicholson J. Vincristine-induced bilateral vocal cord paralysis in children. PediatrBloodCancer. 2007;48(2):248.
10. Gaynon PS. Childhood acute lymphoblastic leukaemiaand relapse. Br J Haematol. 2005;131(5):579-587.
11. Harris CM, Blanchaert RH. Bilateral recurrent laryngeal nerve palsy resulting from treatment with vincristine. J Oral Maxillofac Surg. 2006;64(4):738-739.
12. Graf WD, Chance PF, Lensch MW, Eng LJ, Lipe HP, Bird TD. Severe vincristine neuropathy in Charcot-Marie-Tooth disease type 1A. Cancer. 1996;77(7):1356-1362.
13. McGuire SA, Gospe SM Jr, Dahl G. Acute vincristine neurotoxicity in the presence of hereditary motor and sensory neuropathy type I. Med Pediatr Oncol. 1989; 17(6):520-523.
14. Norman M, Elinder G, Finkel Y. Vincristine neuropathy and a Guillain-Barré syndrome: a case with acute lymphatic leukemia and quadriparesis. Eur J Haematol. 1987;39(1):75-76.
15. Jackson DV Jr, McMahan RA, Pope EK, et al. Clinical trial of folinic acid to reduce vincristine neurotoxicity. Cancer Chemother Pharmacol. 1986;17(3):281-284.
16. Jackson DV Jr, Pope EK, McMahan RA, et al. Clinical trial of pyridoxine to reduce vincristine neurotoxicity. J Neurooncol. 1986;4(1):37-41.
17. Boyle FM, Wheeler HR, Shenfield GM. Glutamate ameliorates experimental vincristine neuropathy. J Pharmacol Exp Ther. 1996;279(1):410-415.
18. Petrini M, Vaglini F, Cervetti G, et al. Is lithium able to reverse neurological damage induced by vinca alkaloids? J Neural Transm. 1999;106(5-6):569-575.